A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.
Eureka Therapeutics Inc.
Pfizer
Pfizer
Bristol-Myers Squibb
H. Lee Moffitt Cancer Center and Research Institute
Eureka Therapeutics Inc.
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
University of Texas Southwestern Medical Center
National Institutes of Health Clinical Center (CC)
Aeon Therapeutics (Shanghai) Co., Ltd.
Daiichi Sankyo
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Merck KGaA, Darmstadt, Germany
Celgene
University of Pittsburgh
University of Louisville
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
Stanford University
James A. Haley Veterans Administration Hospital